LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
28/02/2024
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
I PEACE
ST13
US500000079339458Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
M. Scott Alprin Alprin Law Offices, P.C.
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Cell culture media for laboratory use, other than for medical or veterinary purposes; microorganism culture media for laboratory use, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; chemicals used as ingredients for manufacture of cosmetics; chemicals for industrial purposes; culture fluid for human stem cell as an ingredient for cosmetics manufacturing; stem cells for research and scientific purposes; cell culture media for scientific or research purposes
Classe 3
Cosmetics containing culture fluid for human stem cell; cosmetics; bath and cosmetic soaps and laundry and dishwasher detergents; dentifrices; perfumery
Classe 5
Stem cells for medical purposes; stem cells for clinical medical purposes; stem cells for veterinary purposes; diagnostic media for bacteriological cultures; cell culture media for microorganism culture for medical use; cell culture for medical use; pharmaceutical preparations for human use derived from iPS cells for treating neural disease, muscular disease, heart disease, skin disease, autoimmune disease, kidney disease, eye disease, diabetes, metabolic liver disease, cancers, blood diseases, reproductive organ diseases, lung disease, ear and throat disease, infectious disease, digestive disease and joint disease; pharmaceutical preparations for human use developed by using iPS cells for treating neural disease, muscular disease, heart disease, skin disease, autoimmune disease, kidney disease, eye disease, diabetes, metabolic liver disease, cancers, blood diseases, reproductive organ diseases, lung disease, ear and throat disease, infectious disease, digestive disease and joint disease; dietary supplements; dietetic preparations adapted for medical purposes
Classe 39
Storage of stem cell and cells; warehousing services for deposited frozen stem cell and cells; consultancy and information relating to warehousing services for deposited frozen stem cell and cells; warehousing services
Classe 42
Cell culture services for scientific and research purposes for others; providing scientific information related to cell culture; cytogenetic examination being cytogenic research services for others; testing examination, research and development in the field of regenerative medicine; testing, examination, research and development in the field of cytology; testing, examination, research and development of cosmetics; medical laboratory services; research in the field of pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; conducting clinical trials for pharmaceuticals
Classe 44
Stem cell bank services; medical treatment services by using cultured cells; stem cell therapy services; collection and preservation of stem cells for use in regenerative medicine; collection and preservation of human blood; providing medical information in the field of cells; providing medical information related to regenerative medicine; provision of medical information; medical treatment and diagnosis services by using cultured cells for medical and clinical purposes; medical services; providing information and data for medical diagnosis and treatment; medical treatment and diagnosis by regenerative medicine; medical treatment and diagnosis services by cell therapy; medical treatment and consulting services by cell preparations; medical treatment of speech disorders, breast cancer and infertility, neural disease, muscular disease, heart disease, skin disease, autoimmune disease, kidney disease, eye disease, diabetes, metabolic liver disease, cancers, blood diseases, reproductive organ diseases, lung disease, ear and throat disease, infectious disease, digestive disease and joint disease, not limited to stem cells; preservation of human blood as a supply source of stem cells; clinical medical examination; evaluation of clinical examination for medical purposes; genetic testing for medical purposes; providing medical facilities; Health clinic services; providing health information; dietary and nutritional guidance; rental of medical machines and apparatus
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
28/02/2024
LIMITATION OF GOODS RECEIVED FROM IB
01/01/2024
FINAL DECISION TRANSACTION PROCESSED BY IB
11/12/2023
FINAL DISPOSITION NOTICE SENT TO IB
16/11/2023
FINAL DISPOSITION PROCESSED
15/11/2023
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
15/11/2023
NOTICE OF REGISTRATION CONFIRMATION EMAILED
15/08/2023
REGISTERED-PRINCIPAL REGISTER
15/08/2023
NOTIFICATION PROCESSED BY IB
30/05/2023
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/05/2023
PUBLISHED FOR OPPOSITION
30/05/2023
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/05/2023
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/05/2023
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/05/2023
APPROVED FOR PUB - PRINCIPAL REGISTER
25/04/2023
EXAMINER'S AMENDMENT ENTERED
25/04/2023
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
25/04/2023
EXAMINERS AMENDMENT E-MAILED
25/04/2023
EXAMINERS AMENDMENT -WRITTEN
25/04/2023
NOTIFICATION OF FINAL REFUSAL EMAILED
09/01/2023
FINAL REFUSAL E-MAILED
09/01/2023
FINAL REFUSAL WRITTEN
09/01/2023
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
27/12/2022
TEAS VOLUNTARY AMENDMENT RECEIVED
27/12/2022
REFUSAL PROCESSED BY IB
17/08/2022
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/07/2022
REFUSAL PROCESSED BY MPU
26/07/2022
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/06/2022
NON-FINAL ACTION WRITTEN
27/06/2022
ASSIGNED TO EXAMINER
19/06/2022
APPLICATION FILING RECEIPT MAILED
17/05/2022
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/05/2022
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/05/2022
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/04/2022
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.